Clinical Trials Directory

Trials / Unknown

UnknownNCT04749381

The Role of TCM on ERAS of Rectal Cancer Patients

The Role of Traditional Chinese Medicine on Enhanced Recovery After Surgery for Patients With Rectal Cancer Undergoing Curative Surgery: A Randomized Controlled Trial

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
264 (estimated)
Sponsor
Peking University Cancer Hospital & Institute · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This study is to investigate the role of traditional Chinese medicine (TCM) on the postoperative recovery of rectal cancer patients.

Detailed description

The hypothesis is that TCM can decrease the postoperative complications for rectal cancer. So the study is to investigate the role of traditional Chinese medicine (TCM) on the postoperative recovery of rectal cancer patients. Patients enrolled in this study will be randomized into two groups with TCM intervention or placebo. The intervention will be described below. Primary endpoint is postoperative complications.

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCTacupoint with TCMThe acupoint application was made of traditional Chinese medicine (TCM), and the therapeutic effect was produced through the stimulation of TCM drugs and acupoints.
COMBINATION_PRODUCTacupoint with placeboThe placebo acupoint application was made of black beans and honey, which shares the similar shape and smell of the experiment group, applied at the same acupoints.

Timeline

Start date
2020-09-28
Primary completion
2022-12-30
Completion
2023-02-20
First posted
2021-02-11
Last updated
2021-02-11

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04749381. Inclusion in this directory is not an endorsement.